Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) — Free Cash Flow Generation Index
Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a Free Cash Flow Generation Index of 0.52x as of September 2025. Free cash flow of CN¥60.50 Million represents 1% of operating cash flow (CN¥117.38 Million). Read 600436 liabilities breakdown for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Free Cash Flow Generation Index (2001–2025)
Historical FCF Generation Index trend for Zhangzhou Pientzehuang Pharmaceutical Co Ltd across 24 annual periods. Explore capital reinvestment ratio of Zhangzhou Pientzehuang Pharmaceutical Co to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)
Year-by-year Free Cash Flow Generation Index for Zhangzhou Pientzehuang Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Zhangzhou Pientzehuang Pharmaceutical Co (600436) market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.41x | CN¥-262.77 Million | CN¥77.03 Million | CN¥339.80 Million | ▼ -1926.1% |
| 2024 | 0.19x | CN¥245.41 Million | CN¥1.31 Billion | CN¥1.07 Billion | ▼ -80.0% |
| 2023 | 0.94x | CN¥2.06 Billion | CN¥2.21 Billion | CN¥141.87 Million | ▼ -4.0% |
| 2022 | 0.97x | CN¥6.70 Billion | CN¥6.87 Billion | CN¥175.37 Million | ▲ +21.7% |
| 2021 | 0.80x | CN¥370.11 Million | CN¥462.27 Million | CN¥92.17 Million | ▲ +12.1% |
| 2020 | 0.71x | CN¥1.05 Billion | CN¥1.47 Billion | CN¥419.01 Million | ▼ -18.7% |
| 2018 | 0.88x | CN¥538.08 Million | CN¥612.31 Million | CN¥74.24 Million | ▼ -4.8% |
| 2017 | 0.92x | CN¥625.07 Million | CN¥676.93 Million | CN¥51.87 Million | ▲ +20.0% |
| 2016 | 0.77x | CN¥303.56 Million | CN¥394.54 Million | CN¥90.97 Million | ▲ +3.7% |
| 2015 | 0.74x | CN¥226.65 Million | CN¥305.51 Million | CN¥78.86 Million | ▼ -17.8% |
| 2014 | 0.90x | CN¥238.63 Million | CN¥264.50 Million | CN¥25.87 Million | ▲ +93.7% |
| 2013 | 0.47x | CN¥127.79 Million | CN¥274.34 Million | CN¥146.54 Million | ▲ +954.6% |
| 2012 | 0.04x | CN¥7.17 Million | CN¥162.40 Million | CN¥155.22 Million | ▼ -94.8% |
| 2011 | 0.85x | CN¥197.39 Million | CN¥232.95 Million | CN¥35.56 Million | ▲ +4.5% |
| 2010 | 0.81x | CN¥166.52 Million | CN¥205.41 Million | CN¥38.90 Million | ▲ +5.1% |
| 2009 | 0.77x | CN¥99.85 Million | CN¥129.52 Million | CN¥29.67 Million | ▲ +121.1% |
| 2008 | -3.65x | CN¥-45.93 Million | CN¥12.57 Million | CN¥58.50 Million | ▼ -372.4% |
| 2007 | -0.77x | CN¥-46.43 Million | CN¥60.04 Million | CN¥106.47 Million | ▼ -193.4% |
| 2006 | 0.83x | CN¥41.99 Million | CN¥50.70 Million | CN¥8.71 Million | ▲ +65.7% |
| 2005 | 0.50x | CN¥34.52 Million | CN¥69.06 Million | CN¥34.54 Million | ▼ -43.9% |
| 2004 | 0.89x | CN¥87.92 Million | CN¥98.67 Million | CN¥10.75 Million | ▲ +71.7% |
| 2003 | 0.52x | CN¥16.79 Million | CN¥32.36 Million | CN¥15.56 Million | ▼ -42.8% |
| 2002 | 0.91x | CN¥95.68 Million | CN¥105.45 Million | CN¥9.77 Million | ▲ +10.2% |
| 2001 | 0.82x | CN¥54.20 Million | CN¥65.84 Million | CN¥11.64 Million | — |